Study Detail

Study TypeCancer Genomics
Abstract AML is an unmet medical need and therapeutic progress will not be made without a greater understanding of this heterogeneous disease. The largest subgroup of AML patients lack a cytogenetic abnormality (AML with normal Karyotype, AML-NK). For this reason, the biology of this subtype have been histor .. [more]
Description This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see
Center NameSC